Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. DrugBank 薬物名(臨床試験情報から抽出) KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Cilostazol 2件: Cilostazol; PLETAL1件: D01896 3件: PDE3A,
PDE3B,
TBXA2R 💬
14件: Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 51, 70, 124
2 Dabigatran 1件: Dabigatran1件: D09707 1件: F2 💬8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬4件: 51, 85, 91, 124
3 Donepezil 3件: ARICEPT; DONEPEZIL; Donepezil hydrochloride2件: D00670 ,
D07869
1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬9件: 5, 6, 13, 46, 78, 124, 127, 156, 206
4 Fremanezumab 1件: Fremanezumab1件: D11055 1件: CALCA 💬2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬2件: 124, 226
5 Sapropterin 5件: 6R-BH4; KUVAN; Sapropterin; SAPROPTERIN DIHYDROCHLORIDE; Tetrahydrobiopterin1件: D08505 --5件: 51, 86, 124, 240, 299